The Long-Term Omalizumab Therapy in Children with Severe Persistent Uncontrolled Asthma: Evaluation of the Outcomes According to the Data of the Hospital Patient Registry

The Long-Term Omalizumab Therapy in Children with Severe Persistent Uncontrolled Asthma: Evaluation of the Outcomes According to the Data of the Hospital Patient Registry

Background: Patient registries help to obtain relevant information about the peculiarities of certain diseases, as well as the safety and effectiveness of different medical technologies. Moreover, it allows conducting a continuous monitoring in a studied group. Objective: to analyze the effectivenes...

Full description

Bibliographic Details
Main Authors: Elena A. Vishneva, Leyla S. Namazova-Baranova, Elena A. Dobrynina, Anna A. Alekseeva, Vladimir I. Smirnov, Julia G. Levina, Vera G. Kalugina, Kamilla E. Efendieva, Konstantin S. Volkov
Format: Article
Language:English
Published: Paediatrician Publishers, LLC 2018-05-01
Series:Pediatričeskaâ Farmakologiâ
Subjects:
registry
severe asthma
recombinant monoclonal antibody
omalizumab
long-term therapy
effectiveness
safety
children
Online Access:https://www.pedpharma.ru/jour/article/view/1617

Internet

https://www.pedpharma.ru/jour/article/view/1617

Similar Items